Hepatitis C virus (HCV) is a significant global health concern, affecting millions of people worldwide. It is a member of the Hepacivirus genus within the Flaviviridae family. The HCV genome is a single-stranded positive-sense RNA of approximately 9.6 kb in length, encoding a single polyprotein that is processed into structural and non-structural proteins .
The HCV polyprotein is co- and post-translationally processed by cellular and viral proteases to yield 11 viral proteins. These include three structural proteins (core, E1, and E2), a small polypeptide named p7, and six non-structural (NS) proteins (NS2, NS3, NS4A, NS4B, NS5A, and NS5B) .
The core and NS3 proteins are major immunogenic proteins in HCV infection. They elicit strong humoral and cellular immune responses, making them potential candidates for vaccine development . Various strategies, such as incorporating multiple viral proteins and molecular tags, have been employed to optimize the efficacy of HCV DNA vaccines .